Contingency management for treatment of substance abuse

Annual Review of Clinical Psychology

Volumn 2, Issue , 2006, Pages 411-434

  Stitzer, Maxine ^a   Petry, Nancy ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Behavioral therapy; Drug abstinence; Incentives; Medication compliance; Vouchers

Indexed keywords

CANNABIS; METHADONE; NALTREXONE; OPIATE;

BEHAVIOR THERAPY; CANNABIS ADDICTION; CIGARETTE SMOKING; COCAINE DEPENDENCE; COUNSELING; DRUG DEPENDENCE; DRUG DETOXIFICATION; DRUG WITHDRAWAL; HEALTH CARE COST; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; OPIATE ADDICTION; PARAMETER; PATIENT COMPLIANCE; PSYCHOSOCIAL CARE; REINFORCEMENT; REVIEW; SUBSTANCE ABUSE; TREATMENT PLANNING;

ALCOHOLISM; BEHAVIOR THERAPY; COMBINED MODALITY THERAPY; COUNSELING; HUMANS; METHADONE; NALTREXONE; NARCOTIC ANTAGONISTS; NARCOTICS; PATIENT COMPLIANCE; REINFORCEMENT (PSYCHOLOGY); SUBSTANCE-RELATED DISORDERS; TOKEN ECONOMY; TREATMENT OUTCOME;

EID: 33744489840     PISSN: 15485943     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.clinpsy.2.022305.095219     Document Type: Review

References (76)

1. Alessi SM, Badger GJ, Higgins ST. 2004. An experimental examination of the initial weeks of abstinence in cigarette smokers. Exp. Clin. Psychopharmacol. 12:276-87
2. Benowitz NL. 1996. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol. Rev. 18:188-204
3. Bickel WK, Amass L, Higgins ST, Badger GJ, EschR. 1997. Behavioral treatment improves outcomes during opioid detoxification with buprenorphine. J. Consult. Clin. Psychol. 65:803-10
4. Bigelow GE, Griffiths RR, Liebson IA. 1975. Experimental models for the modification of human drug self-administration: methodological developments in the study of ethanol self-administration by alcoholics. Fed. Proc. 34:1785-92
5. Budney AJ, Higgins ST. 1998. A community reinforcement plus vouchers approach: treating cocaine addiction. NIDA Publ. No. 98-4309, Rockville, MD
6. Budney AJ, Higgins ST, Radonovich KJ, Novy PL. 2000. Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence. J. Consult. Clin. Psychol. 68:1051-61
7. Carroll KE, Ball SA, Nich C, O'Connor PG, Eagan DA, et al. 2001. Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence. Arch. Gen. Psychiatry 58:755-61
8. Carroll KM, Sinha R, Nich C, Babuscio T, Rounsaville BJ. 2002. Contingency management to enhance naltrexone treatment of opioid dependence: a randomized clinical trial of reinforcement magnitude. Exp. Clin. Psychopharmacol. 10:54-63
9. Catania AC. 1966. Concurrent operants. In Operant Behavior: Areas of Research and Application, ed. WK Honig, pp. 213-70. New York: Appleton-Century-Crofts
10. Cox M, Blount JP, Crowe PA, Singh SP. 1996. Diabetic patients' alcohol use and quality of life: relationships with prescribed treatment compliance among older males. Alcohol. Clin. Exp. Res. 20:327-31
11. Dallery J, Silverman K, Chutuape MA, Bigelow GE, Stitzer ML. 2001. Voucher-based reinforcement of opioid plus cocaine abstinence in treatment-resistant methadone patients: effects of reinforcer magnitude. Exp. Clin. Psychopharmacol. 9:317-25
12. Downey KK, Helmus TC, Schuster CR. 2000. Treatment of heroin-dependent polydrug abusers with contingency management and buprenorphine maintenance. Exp. Clin. Psychopharmacol. 8:176-84
13. Epstein DH, Hawkins WE, Covi L, Umbricht A, Preston KL. 2003. Cognitive-behavioral therapy plus contingency management for cocaine use: findings during treatment and across 12-month follow-up. Psychol. Addict. Behav. 17:73-82
14. Ferster CB, Skinner BF. 1957. Schedules of Reinforcement. New York: Appleton-Century-Crofts
15. Gariti P, Rosenthal DI, Lindell K, Hansen-Haschen J, Shrager J, et al. 2002. Validating a dipstick method for detecting recent smoking. Cancer Epidemiol. Biomarkers Prev. 11:1123-25
16. Griffith JD, Rowan-Szal GA, Roark RR, Simpson DD. 2000. Contingency management in outpatient methadone treatment: a meta-analysis. Drug Alcohol. Depend. 58:55-66
17. Gruber K, Chutuape MA, Stitzer ML. 2000. Reinforcement-based intensive outpatient treatment for inner city opioid abusers: a short-term evaluation. Drug Alcohol. Depend. 51:211-23
18. Heil SH, Tidey W, Holmes HW, Badger GJ, Higgins ST. 2003. A contingent payment model of smoking cessation: effects on abstinence and withdrawal. Nicotine Tob. Depend. 5:205-13
19. Higgins ST, Badger GJ, Budney AJ. 2000b. Initial abstinence and success in achieving longer term cocaine abstinence. Exp. Clin. Psychopharmacol. 8:377-86
20. Higgins ST, Budney AJ, Bickel WK, Foerg FE, Donham R, Badger GJ. 1994. Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. Arch. Gen. Psychiatry 51:568-76
21. Higgins ST, Sigmon SC, Wong CJ, Heil SH, Badger GJ, et al. 2003. Community reinforcement therapy for cocaine-dependent outpatients. Arch. Gen. Psychiatry 60:1043-52
22. Higgins ST, Stitzer ML, Bigelow GE, Liebson IA. 1986. Contingent methadone delivery: effects on illicit-opioid use. Drug Alcohol. Depend. 17:311-22
23. Higgins ST, Wong CJ, Badger GJ, Ogden DE, Dantona RA. 2000a. Contingent reinforcement increases cocaine abstinence during outpatient treatment and 1 year of follow-up. J. Consult. Clin. Psychol. 68:64-72
24. Iguchi MY, Belding MA, Morral AR, Lamb RJ. 1997. Reinforcing operants other than abstinence in drug abuse treatment: an effective alternative for reducing drug use. J. Consult. Clin Psychol. 65:421-28
25. Jones HE, Haug N, Silverman K, Stitzer M, Svikis D. 2001. The effectiveness of incentives in enhancing treatment attendance and drug abstinence in methadone-maintained pregnant women. Drug Alcohol. Depend. 61:297-306
26. Jones HE, Haug NA, Stitzer ML, Svikis DC. 2000. Improving treatment outcomes for pregnant drug-dependent women using low-magnitude voucher incentives. Addict. Behav. 25:263-67
27. Jones HE, Johnson RE, Bigelow GE, Silverman K, Mudric T, Strain EC. 2004. Safety and efficacy of L-tryptophan and behavioral incentives for treatment of cocaine dependence: a randomized clinical trial. Am. J. Addictions 13:421-37
28. Jones HE, Wong CJ, Tuten M, Stitzer ML. 2005. Reinforcement-based therapy. 12-month evaluation of an outpatient drug-free treatment for heroin abusers. Drug Alcohol. Depend. 79:119-28
29. Katz EC, Chutuape MA, Jones H, Jasinski D, Fingerhood M, Stitzer M. 2004. Abstinence incentive effects in a short-term outpatient detoxification program. Exp. Clin. Psychopharmacol 12:262-68
30. Katz EC, Robles-Sotelo E, Correia CJ, Silverman K, Stitzer ML, Bigelow G. 2002. The brief abstinence test: Effects of continued incentive availability on cocaine abstinence. Exp. Clin. Psychopharmacol 10:10-17
31. Kidorf M, Stitzer ML, Brooner RK, Goldberg J. 1994. Contingent methadone take-home doses reinforcer adjunct therapy attendance of methadone maintenance patients. Drug Alcohol. Depend. 36:221-26
32. Kirby KC, Marlowe DB, Festinger DS, Lamb RJ, Platt JJ. 1998. Schedule of voucher delivery influences initiation of cocaine abstinence. J. Consult. Clin. Psychol. 66:761-67
33. Kosten T, Oliveto A, Feingold A, Poling J, Sevarino K, et al. 2003. Desipramine and contingency management for cocaine and opioid dependence in buprenorphine maintained patients. Drug Alcohol Depend. 70:315-25
34. McLeod DR, Griffiths RR. 1983. Human progressive-ratio performance: maintenance by pentobarbital. Psychopharmacology 79:4-9
35. Milby JB, Schmacher JE, McNamara C, Wallace D, Usdan S, et al. 2000. Initiating abstinence in cocaine-abusing dually diagnosed homeless persons. Drug Alcohol. Depend. 60:55-67
36. Milby JB, Schumacher JE, Raczynski JM, Caldwell E, Engle M, et al. 1996. Sufficient conditions for effective treatment of substance abusing homeless persons. Drug Alcohol. Depend. 43:39-47
37. Miller P. 1975. A behavioral intervention program for public drunkenness offenders. Arch. Gen. Psychiatry 32:915-18
38. Natl. Res. Counc. Comm. Clin. Eval. Narcotic Antagonists. 1978. Clinical evaluation of naltrexone treatment of opioid-dependent individuals. Arch. Gen. Psychiatry 35:335-40
39. Peirce JM, Petry NM, Stitzer ML, Blaine J, Kolodner K, et al. 2006. Lower-cost incentives increase stimulant abstinence in methadone maintenance community treatment: results of the National Drug Abuse Treatment Clinical Trials Network Multi-site Study. Arch. Gen. Psychiatr. In press
40. Petry NM. 2000. A comprehensive guide to the application of contingency management procedures in general clinic settings. Drug Alcohol. Depend. 58:9-25
41. Petry NM, Alessi SM, Tedford J, Austin M, Tardif M. 2006. Vouchers versus prizes: contingency management treatment of substance abusers in community settings. J. Consult. Clin. Psychol. In press
42. Petry NM, Martin B. 2002. Low-cost contingency management for treating cocaine- and opioid-abusing methadone patients. J. Consult. Clin. Psychol. 70:398-405
43. Petry NM, Martin B, Cooney JL, Kranzler HR. 2000. Give them prizes and they will come: variable-ratio contingency management for treatment of alcohol dependence. J. Consult. Clin. Psychol. 68:250-57
44. Petry NM, Martin B, Simcic F. 2005. Prize reinforcement contingency management for cocaine dependence: integration with group therapy in a methadone clinic. J. Consult. Clin. Psychol. 73:354-59
45. Petry NM, Pierce J, Stitzer ML, Blaine J, Roll JM, et al. 2005. Prize-based incentives improve outcomes of stimulant abusers in outpatient psychosocial treatment programs: a National Drug Abuse Treatment Clinical Trials Network Study. Arch. Gen. Psychiatry 62:1148-56
46. Petry NM, Tedford J, Austin M, Nich C, Carroll KM, Rounsaville BJ. 2004. Prize reinforcement contingency management for treatment of cocaine abusers: How low can we go, and with whom? Addiction 99:349-60
47. Piotrowski NA, Tusel DJ, Sees KL, Reilly P, Banys P, et al. 1999. Contingency contracting with monetary reinforcers for abstinence from multiple drugs in a methadone program. Exp. Clin. Psychopharmacol. 7:399-411
48. Preston KL, Silverman K, Umbricht A, DeJesus A, Montoya ID, Schuster CR. 1999. Improvement in naltrexone treatment compliance with contingency management. Drug Alcohol. Depend. 54:127-35
49. Preston KL, Umbricht A, Epstein DH. 2000. Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance. Arch. Gen. Psychiatry 57:395-404
50. Preston KL, Umbricht A, Wong CJ, Epstein DH. 2001. Shaping cocaine abstinence by successive approximation. J. Consult. Clin. Psychol. 69:643-54
51. Rawson RA, Huber A, McCann M, Shoptaw S, Farabee D, et al. 2002. A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance treatment for cocaine dependence. Arch. Gen. Psychiatry 59:817-24
52. Rhodes GL, Saules KK, Helmus TC, Roll J, BeShears RS, et al. 2003. Improving on-time counseling attendance in a methadone treatment program: a contingency management approach. Am. J. Drug Alcohol Abuse 29:759-73
53. Rigsby MO, Rosen MI, Beauvais JE, Cramer JA, Rainey PM, et al. 2000. Cue-dose training with monetary reinforcement: pilot study of an antiretroviral adherence intervention. J. Gen. Intern. Med. 15:841-47
54. Robles E, Silverman K, Preston KL, Cone EJ, Katz E, et al. 2000. The brief abstinence test: voucher-based reinforcement of cocaine abstinence. Drug Alcohol Depend. 158:205-12
55. Robles E, Stitzer ML, Strain EC, Bigelow GE, Silverman K. 2002. Voucher-based reinforcement of opioid abstinence during methadone detoxification. Drug Alcohol. Depend. 65:179-89
56. Roll J, Higgins ST, Badger GJ. 1996. An experimental comparison of three different schedules of reinforcement of drug abstinence using cigarette smoking as an exemplar. J. Appl. Behav. Anal. 29:495-505
57. Rowan-Szal G, Joe GW, Chatham LR, Simpson DD. 1994. A simple reinforcement system for methadone clients in a community-based treatment program. J. Subst. Abuse Treat. 11:217-23
58. Schwartz B, Lauderdale RM, Montgomery ML, Burch EA, Gallant DM. 1987. Immediate versus delayed feedback on urinalyses reports for methadone maintenance patients. Addict. Behav. 12:293-95
59. Seal KH, Kral AH, Lorvick J, McNees A, Gee L, Edlin BR. 2003. A randomized controlled trial of monetary incentives vs. outreach to enhance adherence to the hepatitis B vaccine series among injection drug users. Drug Alcohol. Depend. 71:127-31
60. Shaner A, Roberts LJ, Eckman TA, Tucker DE, Tsuang JW, et al. 1997. Monetary reinforcement of abstinence from cocaine among mentally ill patients with cocaine dependence. Psychiatr. Serv. 48:807-10
61. Shoptaw S, Rotheram-Fuller E, Yang X, Frosch D, Nahom D, et al. 2002. Smoking cessation in methadone maintenance. Addiction 97:1317-28
62. Sigmon SC, Correia CJ, Stitzer ML. 2004. Cocaine abstinence during methadone maintenance: effects of repeated brief exposure to voucher-based reinforcement. Exp. Clin. Psychopharmacol. 12:269-75
63. Silverman K, Chutuape MAD, Bigelow GE, Stitzer ML. 1999. Voucher-based reinforcement of cocaine abstinence in treatment-resistant methadone patients: effects of reinforcement magnitude. Psychopharmacology 146:128-38
64. Silverman K, Higgins ST, Brooner RK, Montoya ID, Cone EJ, et al. 1996a. Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy. Arch. Gen. Psychiatry 53:409-15
65. Silverman K, Robles E, Mudric T, Bigelow GE, Stitzer ML. 2004. A randomized trial of long-term reinforcement of cocaine abstinence in methadone-maintained patients who inject drugs. J. Consult. Clin. Psychol. 72:839-54
66. Silverman K, Svikis D, Robles E, Stitzer ML, Bigelow GE. 2001. A reinforcement-based therapeutic workplace for the treatment of drug abuse: six-month abstinence outcomes. Exp. Clin. Psychopharmacol. 9:14-23
67. Silverman K, Svikis D, Wong CJ, Hampton J, Stitzer ML, et al. 2002. A reinforcement-based therapeutic workplace for the treatment of drug abuse: three-year abstinence outcomes. Exp. Clin. Psychopharmacol. 10:228-40
68. Silverman K, Wong CJ, Higgins ST, Brooner RK, Montoya ID, et al. 1996b. Increasing opioid abstinence through voucher-based reinforcement therapy. Drug Alcohol. Depend. 41:157-65
69. Silverman K, Wong CJ, Umbricht-Schneiter A, Montoya ID, Schuster CR, Preston KL. 1998. Broad beneficial effects of cocaine abstinence reinforcement among methadone patients. J. Consult. Clin. Psychol. 66:811-24
70. Stitzer ML, Bigelow GE. 1983. Contingent payment for carbon monoxide reduction: effects of pay amount. Behav. Ther. 14:647-56
71. Stitzer ML, Bigelow GE. 1984. Contingent reinforcement for carbon monoxide reduction: within-subjects effects of pay amounts. J. Appl. Behav. Anal. 17:477-83
72. Stitzer ML, Bigelow G, Lawrence C, Cohen J, D'Lugoff B, Hawthorne J. 1977. Medication take-home as a reinforcer in a methadone maintenance program. Addict. Behav. 2:9-14
73. Stitzer ML, Bigelow GE, Liebson IA. 1980. Reducing drug use among methadone maintenance clients: contingent reinforcement for morphine-free urines. Addict. Behav. 5:333-40
74. Stitzer ML, Iguchi MY, Felch LJ. 1992. Contingent take-home incentive: effects on drug use of methadone maintenance patients. J. Consult. Clin. Psychol. 60:927-34
75. Svikis DS, Lee JH, Haug NA, Stitzer ML. 1997. Attendance incentives for outpatient treatment: effects in methadone- and nonmethadone-maintained pregnant drug-dependent women. Drug Alcohol. Depend. 48:33-41
76. Zeiler MD. 1977. Elimination of reinforced behavior: intermittent schedules of not-responding. J. Exp. Anal. Behav. 25:23-32